Plutus Investment Group LLP: Frequently Asked Questions and Contact Information
Learn about Plutus Investment Group LLP, our investment focus, geographic reach and how to contact our team.
Source: Plutus Investment GroupRead article →News & Insights
Verified public updates from Plutus Investment Group and our portfolio companies.
Strada and Navro Partner to Advance End-to-End Global Payroll
Navro announced a strategic partnership with Strada to embed global payment execution into payroll workflows, supporting salary, statutory and third-party disbursements across 95 countries.
Source: NavroRead article →MPC Therapeutics Announces the Commercial Launch of MitoStem™
MPC Therapeutics launched MitoStem™, an ex vivo metabolic enhancer designed to improve CAR-T and engineered cell therapy performance by increasing durable, stem-like T-cell populations.
Source: Plutus / MPC TherapeuticsRead article →Oxford Cancer Biomarkers Expands Clinical Utility of ToxNav®
Oxford Cancer Biomarkers announced a Licence of Technology agreement with Oxford University Innovation to extend the clinical application of its ToxNav® test for chemotherapy toxicity risk.
Source: Plutus / Oxford Cancer BiomarkersRead article →ToxNav® Advantage™ Launches in the U.S. at ASCO GI 2026
Mira Precision Health announced the U.S. launch of ToxNav® Advantage™, a clinically validated pharmacogenomic assay for fluoropyrimidine toxicity risk.
Source: Oxford Cancer Biomarkers / Mira Precision HealthRead article →